Brian Dow - ProSomnus, Common Chief Officer
Executive
Brian Dow is Chief Officer of ProSomnus, Common Stock
| Age | 55 |
| Phone | 844 537 5337 |
| Web | https://www.prosomnus.com |
Brian Dow Latest Insider Activity
Tracking and analyzing the buying and selling activities of Brian Dow against ProSomnus, Common stock is an integral part of due diligence when investing in ProSomnus, Common. Brian Dow insider activity provides valuable insight into whether ProSomnus, Common is net buyers or sellers over its current business cycle. Note, ProSomnus, Common insiders must abide by specific rules, including filing SEC forms every time they buy or sell ProSomnus, Common'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Brian Dow over a year ago Acquisition by Brian Dow of 315742 shares of ProSomnus Common subject to Rule 16b-3 |
ProSomnus, Common Management Efficiency
The company has Return on Asset of (0.4015) % which means that on every $100 spent on assets, it lost $0.4015. This is way below average. ProSomnus, Common's management efficiency ratios could be used to measure how well ProSomnus, Common manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Richard Glaze | CONMED | 59 | |
| Ray Garrison | Orthopediatrics Corp | N/A | |
| Irene Thomas | Neuropace | 55 | |
| Jrme Erath | Pulmonx Corp | N/A | |
| Philip Kowalczyk | LivaNova PLC | N/A | |
| Rosalyn dIncelli | Establishment Labs Holdings | N/A | |
| Michael Levitz | Anika Therapeutics | 50 | |
| Stephanie Walsh | Orthofix Medical | N/A | |
| Andrew Senn | Integer Holdings Corp | 43 | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Mark Namaroff | Anika Therapeutics | 62 | |
| Amy Treadwell | Neuropace | N/A | |
| John Harris | Integer Holdings Corp | 65 | |
| Shana Zink | Treace Medical Concepts | N/A | |
| Nathan Minnich | Treace Medical Concepts | N/A | |
| Frank Vizesi | Orthofix Medical | N/A | |
| Irina Ridley | Neuropace | 38 | |
| RN MBA | CVRx Inc | N/A | |
| Roberto Donadello | Orthofix Medical | N/A | |
| Guy Guglielmino | Treace Medical Concepts | N/A | |
| Ahmet Tezel | LivaNova PLC | N/A | |
Management Performance
| Return On Asset | -0.4 |
ProSomnus, Common Stock Leadership Team
Elected by the shareholders, the ProSomnus, Common's board of directors comprises two types of representatives: ProSomnus, Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProSomnus,. The board's role is to monitor ProSomnus, Common's management team and ensure that shareholders' interests are well served. ProSomnus, Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProSomnus, Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sung Kim, CoFounder CTO | ||
| Mindy Hungerman, Chief Officer | ||
| Jerry Vogel, VP Sales | ||
| Heather Whalen, VP Communications | ||
| Len Liptak, CEO CoFounder | ||
| Shouresh DDS, Global Chair | ||
| Leonard Liptak, CEO CoFounder | ||
| Laing Rikkers, Cofounder Chairman | ||
| Brian Dow, Chief Officer | ||
| John MD, Chief Scientist |
ProSomnus, Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ProSomnus, Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.4 | |||
| Profit Margin | (0.87) % | |||
| Operating Margin | (0.64) % | |||
| Current Valuation | 16.13 M | |||
| Shares Outstanding | 17.39 M | |||
| Shares Owned By Insiders | 20.63 % | |||
| Shares Owned By Institutions | 57.01 % | |||
| Number Of Shares Shorted | 73.91 K | |||
| Price To Sales | 0.30 X | |||
| Revenue | 27.65 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in ProSomnus, Stock
If you are still planning to invest in ProSomnus, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProSomnus, Common's history and understand the potential risks before investing.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |